Cite

HARVARD Citation

    Naidoo, A. et al. (2017). A Review of Moxifloxacin for the Treatment of Drug‐Susceptible Tuberculosis. Journal of clinical pharmacology. pp. 1369-1386. [Online]. 
  
Back to record